Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
| Conditions: | Malignant Mesothelioma |
| Start Date: | April 1, 2010 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT01085630 |
| Study Type: | Interventional |
| Intervention: | Drug: pemetrexed disodium|Other: clinical observation |
| Study Design: | Allocation: Randomized|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Cancer and Leukemia Group B|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 96 |
| Funded By: | Other|NIH |
| First Received: | March 11, 2010 |
| End Date: | |
| Last Updated: | January 12, 2011 |
| Last Verified: | January 1, 2011 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
